A meta-analysis of CSF fms-related tyrosine kinase 3 ligand (Flt3 ligand) revealed that MSA and PD patients had similar levels of Flt3 ligand (SMD = −0.50, 95% CI: -1.48 to 0.48) (Figure S3). Here, FLT3LG is linked to Parkinson disease.